Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Swaminathan Keerthivasagam
Observed name:
S. Keerthivasagam
Institution:
Jawaharlal Institute of Post Graduate Medical Education and Research
Observed institutions:
Homi Bhabha National Institute,
Sri Ramachandra Institute of Higher Education and Research,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer,
Jawaharlal Institute of Post Graduate Medical Education and Research
ORCID:
0000-0003-2834-3868
Observed ORCID:
0000-0003-2834-3868
OpenAlex ID:
A5065902947
Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase ( CML‐CP ) in the tyrosine kinase inhibitor ( TKI ) era—Two decades of experience from the Tata Memorial Hospital paediatric CML ( pCML ) cohort
2023
·
Nirmalya Roy Moulik
, Swaminathan Keerthivasagam
, et al.
·
British Journal of Haematology
·
16
PDF
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
2025
·
Gaurav Narula
, Swaminathan Keerthivasagam
, et al.
·
Blood Cancer Journal
·
15
PDF
Treatment‐Free Remissions in Children With Chronic Myeloid Leukemia ( CML ): A Prospective Study From the Tata Memorial Hospital ( TMH ) Pediatric CML ( pCML ) Cohort
2024
·
Nirmalya Roy Moulik
, Swaminathan Keerthivasagam
, et al.
·
American Journal of Hematology
·
14
PDF
Evaluating the Safety of HCAR19 (Now Actalycabtagene Autoleucel- Actaly-Cel™), a Novel Humanized CD19-Directed Chimeric Antigen Receptor T-Cells in Pediatric, Adolescents, and Young Adults with Relapsed/ Refractory B- Acute Lymphoblastic Leukemia (ESHA) - Report of Phase-1B
2023
·
Gaurav Narula
, Swaminathan Keerthivasagam
, et al.
·
Blood
·
7
Impact of Surveillance Imaging in Detecting Local and Metastatic Lung Recurrences Among Patients with Sarcomas of the Extremities: A Systematic Review and Meta-analysis
2023
·
Shyam Srinivasan
, Swaminathan Keerthivasagam
, et al.
·
Annals of Surgical Oncology
·
5
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India
2023
·
Nirmalya Roy Moulik
, Swaminathan Keerthivasagam
, et al.
·
Annals of Hematology
·
4
Imatinib-induced retroperitoneal fibrosis in a child with chronic myeloid leukemia: a case report.
2021
·
Swaminathan Keerthivasagam
, Nirmalya Roy Moulik
, et al.
·
PubMed
·
4
Does granulocyte transfusion help pediatric cancer patients with sepsis?
2023
·
Swaminathan Keerthivasagam
, Shyam Srinivasan
, et al.
·
Pediatric Blood & Cancer
·
3
Approach to central nervous system leukemia in children from low-middle income countries (LMICs)
2025
·
Malini Maya
, Swaminathan Keerthivasagam
, et al.
·
Pediatric Hematology Oncology Journal
·
2
Transforming Childhood AML Care in India
2024
·
Shyam Srinivasan
, Swaminathan Keerthivasagam
·
Journal of Pediatric Hematology/Oncology
·
2
Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization
2026
·
Santenna Chenchula
, Suresh Kumar Srinivasamurthy
, et al.
·
Pharmaceuticals
·
1
PDF
Dexamethasone-Free Antiemetic Prophylaxis for Children and Adolescents Receiving Highly Emetogenic Chemotherapy: A Multicenter, Phase III, Noninferiority Trial (CIVIC POD)
2026
·
Venkatraman Radhakrishnan
, Prasanth Srinivasan
, et al.
·
Journal of Clinical Oncology
·
1
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study
2025
·
Swetambri Sharma
, Shuvadeep Ganguly
, et al.
·
JMIR Research Protocols
·
1
Ophelia Syndrome: Rare Paraneoplastic Encephalitis Following Complete Metabolic Remission in Hodgkin Lymphoma
2025
·
Srinivas Ananth Kumar
, Vishnu Balgi
, et al.
·
Clinical Nuclear Medicine
·
1
Olanzapine-based, dexamethasone-free antiemetic prophylaxis for highly emetogenic chemotherapy in children and adolescents: A multicenter phase III non-inferiority trial (CIVIC-POD).
2026
·
Venkatraman Radhakrishnan
, Prasanth Srinivasan
, et al.
·
Journal of Clinical Oncology
Olanzapine for weight gain in children undergoing chemotherapy for solid-organ malignancies: An investigator-initiated, open-label, multicenter, phase III randomized controlled trial (SNOWMAN).
2026
·
Shubham Sahni
, Sameer Bakhshi
, et al.
·
Journal of Clinical Oncology
Dexamethasone-free antiemetic prophylaxis with olanzapine in children and adolescents receiving highly emetogenic chemotherapy: A multicenter, phase III non-inferiority randomized trial.
2026
·
Venkatraman Radhakrishnan
, Prasanth Srinivasan
, et al.
·
Journal of Clinical Oncology
School Reintegration After Childhood Cancer: A Mixed-Methods Study from South India
2026
·
Harish Samuthirapandi
, Janani Ravi
, et al.
·
Pediatric Hematology Oncology Journal
PDF
Cardiac Somatostatin-receptor Expression Demonstrated by 68Ga DOTANOC PET/CT in a Child Presenting With Neuroblastoma and Presumed Catecholamine-induced Cardiomyopathy
2025
·
Srinivas Ananth Kumar
, Vishnu Balgi
, et al.
·
Clinical Nuclear Medicine
Burkitt Lymphoma in a Child With Down Syndrome: A Rare Clinical Association
2025
·
Shreyans Patel
, Swaminathan Keerthivasagam
, et al.
·
Pediatric Blood & Cancer
Survival outcomes and prognostic factors in marginal zone lymphoma: A single-center experience from India.
2025
·
Sonit Sai Vasipalli
, Thejas Rao
, et al.
·
Journal of Clinical Oncology
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study
2025
·
Gaurav Narula
, Swaminathan Keerthivasagam
, et al.
·
Blood Cancer Journal
PDF
Clinical profile and outcomes of langerhans cell histiocytosis: A retrospective study from a regional cancer centre in Southern India
2025
·
Vedant Vaidya
, Swaminathan Keerthivasagam
, et al.
·
Pediatric Hematology Oncology Journal
Treatment outcomes of pediatric acute lymphoblastic leukemia using ICiCLe-ALL-14 protocol: Experience from a regional cancer centre in India
2025
·
Swaminathan Keerthivasagam
, Jaikumar GR
, et al.
·
Pediatric Hematology Oncology Journal
A 3-year-old child with multifocal (thoracoabdominal) primary neuroblastoma: A case report and literature review
2024
·
Ayesha Rahmat
, Swaminathan Keerthivasagam
, et al.
·
Pediatric Hematology Oncology Journal
Show more works
View as search
Works count:
28
Citation count:
76
H-index:
5
I10-index:
3
Year
Topic
Type